Quick Answer
BELITE BIO, INC reported Operating Income of -$84.21 million for fiscal year 2025.
BELITE BIO, INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$84.21M | -110.5% |
| 2024 | -$40.00M | -26.3% |
| 2023 | -$31.67M | -147.0% |
| 2022 | -$12.82M | -30.9% |
| 2021 | -$9.80M | -70.6% |
| 2020 | -$5.74M | — |
- BELITE BIO, INC showed a decrease of -110.5% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, BELITE BIO, INC’s operating income has declined by 1366.3% (from -$5.74 million to -$84.21 million).
- The most recent figure is from BELITE BIO, INC’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: